# EDGAR Filing Document

**Accession Number:** 0002088295
**File Stem:** 0001213900-26-061047
**Filing Date:** 2026-5
**Character Count:** 124109
**Document Hash:** 7260d3af68fa80c8705b70d9c67eb611
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-26-061047.hdr.sgml**: 20260526

**ACCESSION NUMBER**: 0001213900-26-061047

**CONFORMED SUBMISSION TYPE**: 425

**PUBLIC DOCUMENT COUNT**: 53

**FILED AS OF DATE**: 20260526

**DATE AS OF CHANGE**: 20260526

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bleichroeder Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0002088295
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-43045
- **FILM NUMBER:** 261020550

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-984-3815

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bleichroeder Acquisition Corp. II
- **CENTRAL INDEX KEY:** 0002088295
- **STANDARD INDUSTRIAL CLASSIFICATION:** BLANK CHECKS [6770]
- **ORGANIZATION NAME:** 05 Real Estate & Construction
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 425

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-984-3815

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **STREET 2:** FLOOR 47
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 8-K**

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(d)**

**OF THE SECURITIES EXCHANGE ACT OF 1934**

**Date of Report (Date of earliest event reported): May 23, 2026**

**Bleichroeder Acquisition Corp. II**

**(Exact name of registrant as specified in its charter)**

---

| | | |
|:---|:---|:---|
| **Cayman Islands** | **001-43045** | **98-1888010** |
| **(State or other jurisdiction<br> of incorporation)** | **(Commission File Number)** | **(IRS Employer <br> Identification No.)** |

---

**1345 Avenue of the Americas, Fl 47<br> New York, NY 10105**

**(Address of principal executive offices, including zip code)**

**Registrant's telephone number, including area code: 212-984-3835**

**Not Applicable**

**(Former name or former address, if changed since last report)**

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☒ Written communications pursuant
to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Trading Symbol(s)** | **Name of each exchange<br> on which registered** |
| Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant | BBCQU | The Nasdaq Stock Market LLC |
| Class A ordinary shares, par value $0.0001 per share | BBCQ | The Nasdaq Stock Market LLC |
| Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share | BBCQW | The Nasdaq Stock Market LLC |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

**Item 1.01 Entry Into a Material Definitive Agreement**

*Amendment to Agreement and Plan of Merger*

 

As previously announced, on February 28, 2026, Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company ("**Parent**" or "**Bleichroeder**"), entered into an Agreement and Plan of Merger (as amended from time to time, the "**Merger Agreement**") by and among Parent, Bleichroeder Acquisition 2 France, a *société par actions simplifiée* formed under the laws of the Republic of France and a wholly owned subsidiary of Parent ("**Parent Merger Sub**"), and Pasqal Holding SAS, a *société par actions simplifiée* formed under the laws of the Republic of France ("**Pasqal**"). The transactions contemplated by the Merger Agreement are hereinafter referred to as the "**Business Combination**."

On May 26, 2026, Parent, Parent Merger Sub, Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France ("**New Merger Sub**"), and Pasqal entered into Amendment No. 1 to the Agreement and Plan of Merger and Assignment and Assumption Agreement (the "**Amendment and Assignment Agreement**"). Among other things, the Amendment and Assignment Agreement provides for the assignment by Parent Merger Sub to New Merger Sub of all of Parent Merger Sub's right, title and interest in, to and under the Merger Agreement, and for New Merger Sub to accept such assignment and assume and agree to observe and perform Parent Merger Sub's duties, obligations, terms, provisions, covenants and liabilities under the Merger Agreement from and after the date thereof.

The Amendment and Assignment Agreement also provides that Parent and Pasqal consent to such assignment and assumption, acknowledge that New Merger Sub will be substituted for Parent Merger Sub as a party and as "Parent Merger Sub" for all purposes under the Merger Agreement, as amended by the Amendment and Assignment Agreement, and release and discharge Parent Merger Sub from obligations arising under the Merger Agreement from and after the date thereof, subject to obligations and liabilities that arose or accrued prior to the date thereof.

In addition, the Amendment and Assignment Agreement amends the Merger Agreement to update the transaction structure and certain related provisions, including changes to recitals and definitions to reflect the contemplated reincorporation and merger mechanics and related financing arrangements, and conforming updates to authorization and capitalization provisions.

The foregoing description of the Amendment and Assignment Agreement is qualified in its entirety by reference to the full text of the Amendment and Assignment Agreement, a copy of which is attached as Exhibit 2.1 hereto and is incorporated herein by reference.

*Amendment to Securities Purchase Agreement*

 

On May 23, 2026, Parent, Parent Merger Sub, Inflection Point Asset Management LLC ("**Inflection Point**") and an accredited investor advised by Inflection Point (the "**New Purchaser**"), entered into Amendment No. 1 (the "**SPA Amendment**") to that certain Securities Purchase Agreement, dated as of March 4, 2026 (the "**SPA**"), by and among Parent, Parent Merger Sub, and the accredited investors named therein (the "**Existing Purchaser**s" and, together with the New Purchaser, the "**Purchasers**").

The SPA Amendment increased the subscription price thereunder by an aggregate of $50.0 million, to $250.0 million (to purchase $312,500,000 aggregate principal amount of Senior Unsecured Convertible Bonds and Investment Warrants related thereto (in each case as defined in the Existing 8-K)), and joined the New Purchaser as an additional Purchaser under the SPA. Except as expressly modified by the SPA Amendment, the SPA shall continue to be and remain in full force and effect in accordance with its original terms, a summary of which is included in the Bleichroeder's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "**SEC**") on March 5, 2026 (the "**Existing 8-K**").

In connection with the Amendment and Assignment Agreement, on May 26, 2026, Parent Merger Sub and New Merger Sub also entered into an Assignment and Assumption Agreement (the "**SPA Assignment Agreement**") in relation to the SPA, pursuant to which New Merger Sub assumed all of Parent Merger Sub's rights and obligations under the SPA and agreed to be bound by all provisions of the SPA applicable to Parent Merger Sub.

The foregoing descriptions of the SPA Amendment and the SPA Assignment Agreement are qualified in their entirety by reference to the SPA Amendment and the SPA Assignment Agreement, copies of which are attached as Exhibit 10.1 and Exhibit 10.2 hereto, respectively, and are incorporated herein by reference.

**Item 7.01 Regulation FD Disclosure**

Furnished as Exhibit 99.1 hereto and incorporated into this Item 7.01 by reference is the investor presentation that Bleichroeder and Pasqal have prepared for use in connection with the Business Combination.

The foregoing (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "**Exchange Act**"), or otherwise be subject to the liabilities of that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act.

**Item 8.01 Other Events.**

On May 26, 2026, Bleichroeder and Pasqal issued a joint press release (the "**Press Release**") announcing the public filing by Parent Merger Sub of a registration statement on Form F-4 with the SEC in connection with the Business Combination and certain other matters. A copy of the Press Release is filed herewith as Exhibit 99.2 and incorporated herein by reference.

**Forward Looking Statements**

This communication contains certain statements that are not historical facts but may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended (the "**Securities Act**"), and Section 21E of the Exchange Act. Forward-looking statements generally are accompanied by words such as "believe," "may," "might," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "could," "plan," "predict," "project," "forecast," "potential," "seem," "seek," "target," "possible," "future," "outlook" or the negatives of these terms or variations of them or similar terminology or expressions that predict or indicate future events or trends or that are not statements of historical matters. These forward-looking statements include, but are not limited to, statements regarding future events, the proposed business combination between Bleichroeder and Pasqal, and other statements that are not historical facts.

These statements are based on the current expectations of Bleichroeder and/or Pasqal's management and are not predictions of actual performance. These forward-looking statements are provided for illustrative purposes only and are not intended to serve as, and must not be relied on, by any investor as a guarantee, an assurance, a prediction or a definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and will differ from assumptions. Many actual events and circumstances are beyond the control of Bleichroeder and Pasqal. These forward-looking statements are subject to a number of known and unknown risks, uncertainties and assumptions regarding Pasqal's business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; uncertainty or changes with respect to taxes, trade conditions and the macroeconomic environment; the inability of the parties to consummate the business combination or the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement entered into in connection to the business combination, including failure by Bleichroeder or Pasqal to receive their respective shareholder approval or required regulatory approvals of the business combination; the number of redemption requests made by Bleichroeder's shareholders in connection with the business combination, leaving the combined company with insufficient cash to execute its business plans; the outcome of any legal proceedings or governmental investigations that may be instituted against the parties following the announcement of the business combination; failure to realize the anticipated benefits of the business combination, including as a result of a delay in consummating the potential transaction; the risk that the business combination disrupts Pasqal's current plans and operations as a result of the announcement and consummation of the business combination; the risks related to Pasqal meeting expected business milestones; the effects of competition on Pasqal's business; the ability of the combined company to execute its growth strategy, manage growth profitably and retain its key employees; the ability of the combined company to obtain or maintain the listing of its securities on a U.S. national securities exchange following the business combination; the ability to achieve dual listing on Euronext N.V. Paris following the business combination; costs related to the business combination; the ability of Bleichroeder or the combined company to raise capital or issue debt, equity or equity-linked securities in connection with the proposed business combination or in the future on reasonable terms or at all; the combined company's ability to maintain internal control over financial reporting and operate as a public company; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal's financial performance and limited operating history; Pasqal's expectations regarding future financial performance, capital requirements and unit economics; Pasqal's use and reporting of business and operational metrics; Pasqal's competitive landscape; Pasqal's dependence on members of its senior management and its ability to attract and retain qualified personnel; Pasqal's potential need for additional future financing prior to or after the business combination as a combined company; Pasqal's concentration of revenue in contracts with government or state-funded entities; Pasqal's ability to manage growth and expand its operations; potential future acquisitions or investments in companies, products, services or technologies; Pasqal's reliance on strategic partners and other third parties; Pasqal's ability to maintain, protect and defend its intellectual property rights; risks associated with privacy, data protection or cybersecurity incidents and related regulations; the use, rate of adoption and regulation of artificial intelligence and machine learning; and other risks that will be detailed from time to time in filings with the SEC. The foregoing list of risk factors is not exhaustive. There may be additional risks that Pasqal and Bleichroeder presently do not know or that Pasqal and Bleichroeder currently believe are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Pasqal's and/or Bleichroeder's expectations, plans and forecasts of future events and views as of the date of this communication. Pasqal and Bleichroeder anticipate that subsequent events and developments will cause their assessments to change. However, while Pasqal and/or Bleichroeder may elect to update these forward-looking statements in the future, Pasqal and Bleichroeder specifically disclaim any obligation to do so. These forward-looking statements should not be relied upon as representing Pasqal's or Bleichroeder's assessments as of any date subsequent to the date of this communication. Accordingly, undue reliance should not be placed upon the forward-looking statements. Nothing herein should be regarded as a representation by any person that the forward-looking statements set forth herein will be achieved or results of such forward-looking statements will be achieved.

An investment in Bleichroeder is not an investment in any of its founders' or sponsors' past investments, companies or affiliated funds. The historical results of those investments are not indicative of future performance of Bleichroeder, which may differ materially.

**Additional Information and Where to Find It**

The business combination will be submitted to shareholders of Bleichroeder for their consideration. In connection with the business combination, Bleichroeder, Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France and Pasqal have jointly filed a registration statement on Form F-4 (the "**Registration Statemen**t") with the SEC, which includes a proxy statement/prospectus and certain other related documents, which will serve as both the proxy statement/prospectus to be distributed to its shareholders in connection with its solicitation for proxies for the vote by its shareholders in connection with the business combination and other matters to be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued to Pasqal's shareholders in connection with the completion of the business combination. After the Registration Statement is declared effective, Bleichroeder will mail a definitive proxy statement/prospectus and other relevant documents to its shareholders as of the record date established for voting on the business combination. This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Bleichroeder will send to its shareholders in connection with the business combination.

BEFORE MAKING ANY INVESTMENT OR VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS AND, IN EACH CASE, ANY AMENDMENTS THERETO FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION, RELATED TRANSACTIONS AND THE PARTIES TO THE BUSINESS COMBINATION. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge at www.sec.gov. The definitive proxy statement/final prospectus (if and when available) will be mailed to shareholders of Bleichroeder as of a record date to be established for voting on the business combination. Shareholders of Bleichroeder will also be able to obtain copies of the proxy statement/prospectus without charge, once available, at the SEC's website at www.sec.gov.

**Participants in the Solicitation**

Bleichroeder and its directors, executive officers, and other members of management, and consultants, under SEC rules, may be deemed participants in the solicitation of proxies from Bleichroeder's shareholders with respect to the business combination. A list of the names of those directors and executive officers and a description of their interests in Bleichroeder and the business combination is contained in the sections entitled "Directors, Executive Officers and Corporate Governance," "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters," and "Certain Relationships and Related Transactions, and Director Independence" of the Annual Report filed by Bleichroeder with the SEC on March 16, 2026 and the Current Report on Form 8-K filed with the SEC on May 1, 2026, and each of which is available free of charge at the SEC's website at www.sec.gov. Additional information regarding the interests of participants in the proxy solicitation and their direct and indirect interests will be contained in the Registration Statement and the proxy statement/prospectus when they become available.

Pasqal, its directors, executive officers, other members of management, employees and consultants, under SEC rules, may be deemed participants in the solicitation of proxies of Bleichroeder's shareholders in connection with the business combination. A list of the names of such directors and executive officers and information regarding their interests in the business combination will be included in the Registration Statement and the proxy statement/prospectus when they become available.

**No Offer or Solicitation**

This communication is for informational purposes only and is not (i) an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law nor (ii) the solicitation of any vote in any jurisdiction pursuant to the business combination or otherwise. This communication is not, and under no circumstances is to be construed as, a prospectus, an advertisement or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act or exemptions therefrom. No securities commission or securities regulatory authority in the United States or any other jurisdiction has in any way passed upon the merits of the business combination or the accuracy or adequacy of this communication.

**Item 9.01 Financial Statements and Exhibits**

(d) Exhibits:

---

| | |
|:---|:---|
| **Exhibit No.** | **Description** |
| 2.1 | [Amendment No. 1 to the Agreement and Plan of Merger, dated as of May 26, 2026, by and among Bleichroeder Acquisition Corp. II, Bleichroeder Acquisition 2 France, Bleichroeder Acquisition France Merger Sub 2 and Pasqal Holding SAS.](ea029211101ex2-1.htm) |
| 10.1 | [Amendment No. 1, dated May 23, 2026, by and among, Bleichroeder Acquisition Corp. II, Bleichroeder Acquisition 2 France, and the purchasers identified on the signature pages thereto, to the Securities Purchase Agreement, dated March 4, 2026, by and among, Bleichroeder Acquisition Corp. II, Bleichroeder Acquisition 2 France, and the purchasers identified on the signature pages thereto.](ea029211101ex10-1.htm) |
| 10.2 | [Assignment and Assumption Agreement, dated as of May 26, 2026, by and between Bleichroeder Acquisition 2 France and Bleichroeder Acquisition France Merger Sub 2.](ea029211101ex10-2.htm) |
| 99.1 | [Investor Presentation, dated May 2026.](ea029211101ex99-1.htm) |
| 99.2 | [Press Release, dated May 26, 2026.](ea029211101ex99-2.htm) |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). |

---

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | | |
|:---|:---|:---|:---|
|  | **BLEICHROEDER ACQUISITION CORP. II** | **BLEICHROEDER ACQUISITION CORP. II** | **BLEICHROEDER ACQUISITION CORP. II** |
| Date: May 26, 2026 | By: | /s/ Marcello Padula | /s/ Marcello Padula |
|  |  | Name: | Marcello Padula |
|  |  | Title: | Chief Executive Officer and Chief Operating Officer |

---

## Exhibit 2.1

**Exhibit 2.1**

**AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER**

**AND** 

**ASSIGNMENT AND ASSUMPTION AGREEMENT**

This AMENDMENT NO. 1 to the AGREEMENT AND PLAN OF MERGER, dated as of May 26, 2026 (this "***Amendment***"), is made by and between Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company ("***Parent***"), Bleichroeder Acquisition 2 France, a *société par actions simplifiée* formed under the laws of the Republic of France and wholly owned subsidiary of Parent (the "***Parent Merger Sub***"), Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France ("***New Merger Sub***"), and Pasqal Holding SAS, a *société par actions simplifiée* formed under the laws of the Republic of France (the "***Company***"). Parent, Parent Merger Sub and the Company shall each be referred to herein from time to time individually as a "***Party***" and collectively as the "***Parties***".

**RECITALS:**

**WHEREAS**, Parent, Parent Merger Sub and the Company are parties to that certain Agreement and Plan of Merger, dated as of February 28, 2026 (as may be amended or supplemented from time to time, the "***Business Combination Agreement***");

**WHEREAS**, in connection with the Transactions, Parent Merger Sub desires to assign, and New Merger Sub desires to assume, all of Parent Merger Sub's rights and obligations under the Business Combination Agreement, and each of Parent and the Company desires to consent to such assignment and assumption and to acknowledge the substitution of New Merger Sub for Parent Merger Sub as a party to the Business Combination Agreement;

**WHEREAS**, pursuant to Section 11.6 of the Business Combination Agreement, the Business Combination Agreement may be amended or waived prior to the Effective Time if, but only if, such amendment or waiver is in writing and executed by the Parties; and

**WHEREAS**, the Parties desire to amend the Business Combination Agreement as hereinafter set forth.

**NOW, THEREFORE** for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties hereby agree as follows:

&nbsp;&nbsp;&nbsp;&nbsp;1. <u>Definitions</u>. Capitalized terms used in this Amendment and not otherwise defined herein shall
 have the respective meanings ascribed to them in the Business Combination Agreement.

&nbsp;&nbsp;&nbsp;&nbsp;2. <u>Assignment and Assumption</u>. Effective as of the date hereof, Parent Merger Sub hereby irrevocably
assigns, transfers, conveys and delivers to New Merger Sub all of Parent Merger Sub's right, title and interest in, to and under
the Business Combination Agreement, including all of Parent Merger Sub's rights, benefits and privileges thereunder. New Merger
Sub hereby accepts such assignment and assumes and agrees to observe and perform all of the duties, obligations, terms, provisions and
covenants, and to pay and discharge all of the liabilities of Parent Merger Sub to be observed, performed, paid or discharged in connection
with the Business Combination Agreement. Each of Parent and the Company hereby (i) consents to the assignment and assumption pursuant
to and in accordance with Section 11.7 of the Business Combination Agreement, (ii) acknowledges and agrees that, effective as of the date
hereof, New Merger Sub shall be substituted for Parent Merger Sub as a "Party" and as "Parent Merger Sub" for
all purposes under the Business Combination Agreement, as amended by this Amendment, and all references in the Business Combination Agreement
to "Parent Merger Sub" shall be deemed to refer to New Merger Sub, and (iii) releases and discharges Parent Merger Sub from
any and all obligations arising under the Business Combination Agreement from and after the date hereof. Notwithstanding the foregoing,
nothing in this Section 2 shall be deemed to release Parent Merger Sub from any obligation or liability under the Business Combination
Agreement that arose or accrued prior to the date hereof.

&nbsp;&nbsp;&nbsp;&nbsp;3. <u>Amendments</u>. The Business Combination Agreement is hereby amended as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;a. The introductory paragraph of the Business Combination Agreement is hereby amended
and restated by deleting "Bleichroeder Acquisition 2 France, a *société par actions simplifiée* formed
under the laws of the Republic of France and wholly owned subsidiary of Parent" and replacing it with "Bleichroeder Acquisition
France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France," and any references
to Parent Merger Sub shall be deemed to refer to Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;b. The fourth WHEREAS clause of the Preamble is hereby deleted in its entirety and
replaced with the following:

"WHEREAS, Parent Merger Sub exists for the purpose of effectuating the Transactions, including the merger of Parent with and into Parent Merger Sub (the "<u>Reincorporation Merger</u>"), in which Parent Merger Sub will be the surviving entity of the Reincorporation Merger (the "<u>Parent Surviving Corporation</u>")."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c. The ninth WHEREAS clause of the Preamble is hereby deleted in its entirety and replaced
with the following

"WHEREAS**,** as a condition and inducement to the Parties' willingness to enter into this Agreement, concurrently with the execution and delivery of this Agreement, Parent and Parent Merger Sub, on the one hand and on behalf of the Surviving Corporation, and certain investors named therein (the "<u>Pre-PIPE Investors</u>"), on the other hand, have executed and delivered that certain securities purchase agreement (the "<u>Pre-PIPE SPA</u>"), pursuant to which the Pre-PIPE Investors have agreed, among other things, to subscribe from the Surviving Corporation, and Parent and Parent Merger Sub have agreed, among other things, to issue to such investors, for an aggregate issue amount of not less than $150 million, (a) senior unsecured convertible bonds of the Surviving Corporation convertible into Surviving Corporation Shares, governed by French law (the "<u>Convertible Bonds</u>"), having the rights, preferences and privileges substantially consistent with terms set forth in Exhibit A to the Pre-PIPE SPA, to be attached to the Surviving Corporation's shareholders decision authorizing the issuance of the Convertible Bonds (the "<u>Convertible Bonds Terms and Conditions</u>") and (b) warrants (*bons de souscription d'actions*) to purchase Surviving Corporation Shares, governed by French law (the "<u>Pre-PIPE Warrants</u>"), having the rights, preferences and privileges substantially consistent with the terms set forth in Exhibit A to the Pre-PIPE SPA, to be attached to the Surviving Corporation's shareholders decision authorizing the issuance of the Pre-Pipe Warrants (the "<u>Pre-PIPE Warrants Terms and Conditions</u>"), pursuant to subscription forms relating to the subscription for (i) the Convertible Bonds and (ii) the Pre-PIPE Warrants (each a "<u>Pre-PIPE Subscription Agreement</u>" and, collectively the "<u>Pre-PIPE Subscription Agreements</u>"), in each case to be delivered substantially concurrently with the Closing (such investment, the "<u>Pre-PIPE Investment</u>")."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;d. The final WHEREAS clause of the Business Combination Agreement is hereby deleted
in its entirety and replaced with the following:

"WHEREAS, the board of directors of Parent Merger Sub (the "<u>Parent Merger Sub Board</u>") has (i) determined that this Agreement, the Additional Agreements to which Parent Merger Sub is a party, the Mergers, and the other Transactions are fair and advisable to, and in the best interests of, Parent Merger Sub and the shareholders of Parent Merger Sub, in their respective capacities as shareholders of Parent Merger Sub, and (ii) approved and adopted this Agreement, the Additional Agreements to which Parent Merger Sub is a party, the Mergers and the other Transactions."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;e. The definition of "Parent Merger Sub Shares" is hereby deleted in its
entirety and replaced with the following:

"<u>Parent Merger Sub Shares</u>" means the ordinary shares, of par value €.10 each, of Parent Merger Sub.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;f. The last sentence of Section 2.1(a) of the Business Combination Agreement is hereby
deleted in its entirety.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;g. The last sentence of Section 2.1(f)(iii) of the Business Combination Agreement is
hereby deleted in its entirety and replaced with the following:

"In addition, as of the Reincorporation Merger Effective Time, each Parent Merger Sub Share issued and outstanding immediately prior to the Reincorporation Merger Effective Time, whether held by Parent or by any other shareholder of Parent Merger Sub, will be automatically cancelled and extinguished without any conversion or consideration delivered in exchange therefor."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;h. Section 5.2(a) of the Business Combination Agreement is hereby deleted in its entirety
and replaced with the following:

"The execution, delivery and performance by each of the Parent Parties of this Agreement and the Additional Agreements (to which it is a party) and the consummation by each of the Parent Parties of the Transactions are within the corporate powers of such Parent Parties and have been duly authorized by all necessary corporate action, including the Parent Board Recommendation, on the part of the Parent Parties to the extent required by their respective Organizational Documents, other than the Required Parent Shareholder Approval, the approval of the shareholders of Parent Merger Sub approving the Reincorporation Merger, and the required approval of the Merger by the shareholders of Parent Surviving Corporation. This Agreement has been duly executed and delivered by the Parent Parties and it and the Additional Agreements (to which each of them is a party) will constitute upon execution and delivery by all parties, a valid and legally binding agreement of the Parent Parties, enforceable against them in accordance with their respective terms except for the Enforceability Exceptions."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;i. Section 5.2(b) of the Business Combination Agreement is hereby deleted in its entirety
and replaced with the following:

"<u>Parent Board Approval; Parent Shareholder Vote</u>. The Parent Board (including any required committee or subgroup of the Parent Board) and the shareholders of Parent Merger Sub have, as of the date of this Agreement, unanimously (i) approved and declared the advisability of this Agreement, the other Additional Agreements, and the consummation of the Transactions, and (ii) determined that the consummation of the Transactions is in the best interest of, as applicable, Parent and shareholders of Parent (as a whole). Other than the Required Shareholder Approval, no other corporate proceedings on the part of Parent are necessary to approve the consummation of the Transactions."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;j. Section 5.5(b)(i) of the Business Combination Agreement is hereby deleted in its
entirety and replaced with the following:

"The authorized share capital of Parent Merger Sub is €50,000, divided into 500,000 Parent Merger Sub Shares, of which 500,000 Parent Merger Sub Shares are issued and outstanding as of such time, of which 499,990 Parent Merger Sub Shares are held by Parent and 10 Parent Merger Sub Shares are held by Michel Combes. No other voting securities of Parent Merger Sub are issued, reserved for issuance or outstanding."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;k. The first sentence of Section 5.5(b)(iv) of the Business Combination Agreement is
hereby deleted in its entirety and replaced with the following:

"The share capital of Parent Merger Sub is owned by Parent and Michel Combes, and Parent Merger Sub was formed for the purpose of the Reincorporation Merger."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;l. Section 5.6 of the Business Combination Agreement is hereby deleted in its entirety
and replaced with the following:

"<u>Subsidiaries</u>. Other than its equity interest in Parent Merger Sub, Parent has no other Subsidiaries or equity interests in any other Person."

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;m. Section 8.8(c) of the Business Combination Agreement is hereby deleted in its entirety
and replaced with the following:

"<u>Name Change</u>. Prior to the consummation of the Merger, Parent Merger Sub shareholders will decide to change, and take all actions necessary to change, the name of Parent Merger Sub to "Pasqal Holding SA" or such other name selected by the Company and such name change shall become effective immediately prior to or substantially simultaneously with the consummation of the Merger. Immediately after the consummation of the Merger, Parent Merger Sub will file with the trade and companies register any documents required to update the trade and companies register."

&nbsp;&nbsp;&nbsp;&nbsp;4. <u>Effect of this Amendment</u>. Except as expressly provided by this Amendment,
each of the provisions of the Business Combination Agreement shall remain unchanged and in full force and effect following the execution
of this Amendment. Following the execution of this Amendment, references in the Business Combination Agreement to "this Agreement",
"herein", "hereof" or phrases having a similar meaning shall refer to the Business Combination Agreement as amended
by this Amendment.

&nbsp;&nbsp;&nbsp;&nbsp;5. <u>Entire Agreement</u>. This Amendment and the Business Combination Agreement constitute the entire
 agreement among the Parties with respect to the subject matter hereof and supersedes all other prior agreements and understandings,
 both written and oral, among the Parties or any of their respective Subsidiaries with respect to the subject matter hereof.

&nbsp;&nbsp;&nbsp;&nbsp;6. <u>General Provisions</u>. Section 11.3 (*Notices*), Section 11.5 (*Severability*),
Section 11.10 (*Counterparts*), and Section 11.9 (*Governing Law; Dispute Resolution Provisions*) of the Business Combination
Agreement are incorporated herein by reference and shall apply, *mutatis mutandis*, to this Amendment as though fully set forth herein.

 

*[Signature pages follow]*

IN WITNESS WHEREOF, the Parties hereto have caused this Amendment to be executed by their respective authorized representatives as of the date first written above.

---

| | | |
|:---|:---|:---|
| **Bleichroeder Acquisition Corp. II** | **Bleichroeder Acquisition Corp. II** | **Bleichroeder Acquisition Corp. II** |
| By: | /s/ Marcello Padula | /s/ Marcello Padula |
|  | Name: | Marcello Padula |
|  | Title: | Chief Executive Officer |
| **BLEICHROEDER ACQUISITION 2 FRANCE** | **BLEICHROEDER ACQUISITION 2 FRANCE** | **BLEICHROEDER ACQUISITION 2 FRANCE** |
| By: | /s/ Michel Combes | /s/ Michel Combes |
|  | Name: | Michel Combes |
|  | Title: | President |
| **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** | **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** | **BLEICHROEDER ACQUISITION FRANCE MERGER SUB 2** |
| By: | /s/ Michel Combes | /s/ Michel Combes |
|  | Name: | Michel Combes |
|  | Title: | President |
| **PASQAL HOLDING SAS** | **PASQAL HOLDING SAS** | **PASQAL HOLDING SAS** |
| By: | /s/ Wasiq Bokhari | /s/ Wasiq Bokhari |
|  | Name: | Mr. Wasiq Bokhari |
|  | Title: | President |

---

## Exhibit 10.1

**Exhibit 10.1**

**AMENDMENT NO. 1 TO SECURITIES PURCHASE AGREEMENT**

This Amendment No. 1 (this "**Amendment**") to that certain Securities Purchase Agreement (the "**Purchase Agreement**"), dated as of March 4, 2026, by and among Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company (the "**Company**"), Bleichroeder Acquisition 2 France, a *société par actions simplifiée* formed under the laws of the Republic of France and wholly owned subsidiary of the Company ("**Merger Sub**", and together with the Company, the "**SPAC Parties**"), and the purchasers identified on the signature pages thereto, including any purchaser's successors and assigns (collectively, the "**Existing Purchasers**"), is entered into by and among the Company, Merger Sub, Inflection Point Fund I, LP ("**Inflection Point**") and the additional purchasers identified on the signature pages hereto (collectively, the "**New Purchasers**" and, together with the Existing Purchasers, the "**Purchasers**" and each a "**Purchaser**"), effective as of May 23, 2026 (the "**Effective Date**").

**WHEREAS,** Section 5.5 of the Purchase Agreement provides that Schedule A thereto may be amended by a written instrument signed by the Company, Merger Sub and Inflection Point to increase Inflection Point's Subscription Amount by an aggregate amount of up to $50.0 million, without the consent of any other Purchasers;

**WHEREAS,** such additional investment may be made by Inflection Point or by any one or more investment funds, vehicles or accounts managed, advised or controlled by Inflection Point or any of its Affiliates, as designated by Inflection Point in its sole discretion;

**WHEREAS,** Inflection Point desires to increase its Subscription Amount by an aggregate amount of $50.0 million, to be made by Inflection Point and certain investment funds, vehicles or accounts managed, advised or controlled by Inflection Point or any of its Affiliates;

**WHEREAS**, the parties desire to (i) join the New Purchasers as additional "Purchasers" under the Purchase Agreement on the same terms and conditions applicable to the Existing Purchasers, (ii) increase the aggregate offering size under the Purchase Agreement, and (iii) amend Schedule A to the Purchase Agreement, in each case as more fully set forth herein; and

**WHEREAS,** the New Purchasers desire to become party to, and be bound by the terms and conditions of, the Purchase Agreement, as amended hereby.

**NOW, THEREFORE, IN CONSIDERATION** of the mutual covenants contained in this Amendment, and for other good and valuable consideration the receipt and adequacy of which are hereby acknowledged, the Company, Merger Sub, Inflection Point and the New Purchasers agree as follows:

**ARTICLE 1**

**DEFINITIONS**

1.1 **<u>Definitions</u>**. Capitalized terms used and not defined in this Amendment have the respective meanings ascribed to them in the Purchase Agreement.

**ARTICLE 2**

**AMENDMENTS TO THE PURCHASE AGREEMENT**

2.1 **<u>Joinder of New Purchasers</u>**.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) Effective as of the date hereof, each New Purchaser shall have all of the rights of a Purchaser under the Purchase Agreement and hereby (i) acknowledges that it has received and reviewed a complete copy of the Purchase Agreement and all exhibits and schedules thereto; (ii) agrees to be bound as a "Purchaser" by all of the terms, conditions, and provisions of the Purchase Agreement as if it had been an original signatory thereto; and (iii) assumes all of the obligations and liabilities of a Purchaser under the Purchase Agreement with respect to the Securities being purchased by such New Purchaser.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) Each New Purchaser, severally and not jointly, hereby represents and warrants as of the date of this Amendment and as of the Closing Date (or, if such representations and warranties are made with respect to a specified date, as of such date) each of the representations and warranties of a "Purchaser" set forth in Section 3.2 of the Purchase Agreement. Without limiting the foregoing, each New Purchaser has provided the SPAC Parties with the requested information on Schedule B of the Purchase Agreement and represents and warrants that such information is accurate and complete.

2.2 **<u>Amendment to Schedule A</u>**. As of the Effective Date, Schedule A of the Purchase Agreement is hereby replaced in its entirety with Schedule A hereto.

**ARTICLE 3**

**MISCELLANEOUS**

3.1 **<u>Execution</u>**. This Amendment may be executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to each other party, it being understood that the parties need not sign the same counterpart. In the event that any signature is delivered by e-mail delivery of a ".pdf" format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such ".pdf" signature page were an original thereof.

3.2 **<u>Jurisdiction</u>**. All questions concerning the construction, validity, enforcement and interpretation of this Amendment shall be determined in accordance with the provisions of the Purchase Agreement.

3.3 **<u>Continuation of SPA</u>**. Except as expressly modified by this Amendment, the Purchase Agreement shall continue to be and remain in full force and effect in accordance with its original terms. Any future reference to the Purchase Agreement shall be deemed to be a reference to the Purchase Agreement as modified by this Amendment.

*(Signature Pages Follow)*

IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1 to the Securities Purchase Agreement to be duly executed by their respective authorized signatories as of the date first indicated above.

---

| | |
|:---|:---|
| BLEICHROEDER ACQUISITION CORP. II | BLEICHROEDER ACQUISITION CORP. II |
| By: | /s/ Marcello Padula |
| Name: | Marcello Padula |
| Title: | Chief Executive Officer |
| BLEICHROEDER ACQUISITION 2 FRANCE | BLEICHROEDER ACQUISITION 2 FRANCE |
| By: | /s/ Michel Combes |
| Name: | Michel Combes |
| Title: | President |
| INFLECTION POINT FUND I, LP | INFLECTION POINT FUND I, LP |
| By: | /s/ Mike Blitzer |
| Name: | Mike Blitzer |
| Title: | Managing Partner |

---

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

*[Signature Page to Amendment No. 1 to Securities Purchase Agreement]*

**NEW PURCHASER**

<br> Name of Purchaser: Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B

 

*Signature of Authorized Signatory of Purchaser*: <u>/s/ Waqas Khatri</u>

Name of Authorized Signatory: <u>Waqas Khatri</u>

Title of Authorized Signatory: <u>Director</u>

Email Address of Authorized Signatory: <u>[\*\*\*]</u>

Address for Notice to Purchaser: <u>c/o [\*\*\*]</u>

Address for Delivery of Securities to Purchaser (if not same as address for notice):

______________________________________________________________________

EIN Number: [\*\*\*]

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

*[Signature Page to Amendment No. 1 to Securities Purchase Agreement]*

**SCHEDULE A**

**Schedule of Purchasers**

[\*\*\*]

## Exhibit 10.2

**Exhibit 10.2**

**ASSIGNMENT AND ASSUMPTION AGREEMENT**

This Assignment and Assumption Agreement (this "**Agreement**") is entered into as of May 26, 2026, by and between:

**Bleichroeder Acquisition 2 France**, a *société par actions simplifiée* formed under the laws of the Republic of France ("**Assignor**"); and

**Bleichroeder Acquisition France Merger Sub 2**, a *société anonyme* formed under the laws of the Republic of France ("**Assignee**").

**RECITALS**

**WHEREAS,** Assignor previously entered into that certain Securities Purchase Agreement, dated as of March 4, 2026 (as amended, restated, supplemented or otherwise modified from time to time, the "**SPA**"), by and among Assignor, Bleichroeder Acquisition Corp. II, a Cayman Islands exempted company (the "**Company**"), and the purchasers identified on the signature pages thereto.

**WHEREAS,** pursuant to that certain Written Consent to Assignment, dated as of May 26, 2026, the Company and the Purchasers (as defined in the SPA) have consented to the assignment by Assignor of the SPA and all of Assignor's rights and obligations thereunder to Assignee, effective as of the date hereof (the "**Assignment**").

**WHEREAS,** the Written Consent to Assignment requires Assignee to execute and deliver this Agreement as a condition to the effectiveness of the Assignment.

**NOW, THEREFORE**, in consideration of the foregoing and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Assignee hereby agrees as follows:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**1.** **Assumption of Rights and Obligations**. Effective as of the date hereof, Assignee hereby assumes
and agrees to perform and discharge all of Assignor's rights and obligations under the SPA arising from and after the date hereof
(the "**Effective Date** "), with the same force and effect as if Assignee had originally been a party to the SPA as "Merger
Sub." For the avoidance of doubt, Assignor shall remain liable for all obligations under the SPA that arose prior to the Effective
Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**2.** **Joinder to Transaction Documents**. Assignee hereby agrees to be bound by all provisions of the Transaction
Documents (as defined in the SPA) that apply to "Merger Sub," and Assignee shall have all of the rights, and be subject to
all of the obligations, of "Merger Sub" thereunder from and after the Effective Date.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**3.** **Representations**. Assignee represents and warrants that (i) it is duly formed and validly existing
under the laws of the Republic of France, (ii) it has the power and authority to execute and deliver this Agreement and to perform its
obligations hereunder and under the Transaction Documents, and (iii) this Agreement has been duly authorized, executed and delivered by
Assignee and constitutes a legal, valid and binding obligation of Assignee, enforceable against it in accordance with its terms, subject
to applicable bankruptcy, insolvency, reorganization, moratorium and similar laws affecting creditors' rights generally and to general
principles of equity.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**4.** **No Other Amendment**. Except as expressly set forth herein, the SPA and the other Transaction Documents
remain in full force and effect and are hereby ratified and confirmed in all respects.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**5.** **Miscellaneous.** This Agreement shall be governed by and construed in accordance with the governing
law provisions of the SPA. This Agreement may be executed in one or more counterparts (including by electronic signature), each of which
shall be deemed an original, and all of which together shall constitute one and the same instrument.

Capitalized terms used but not defined herein have the meanings ascribed to them in the SPA.

IN WITNESS WHEREOF, the parties hereto have executed this Assignment and Assumption Agreement as of the date first written above.

---

| | |
|:---|:---|
| **BLEICHROEDER ACQUISITION 2 FRANCE** | **BLEICHROEDER ACQUISITION 2 FRANCE** |
| By: | /s/ Michel Combes |
| Name: | Michel Combes |
| Title: | President |
| **BLEICHROEDER ACQUISITION FRANCE** | **BLEICHROEDER ACQUISITION FRANCE** |
| **MERGER SUB 2** | **MERGER SUB 2** |
| By: | /s/ Michel Combes |
| Name: | Michel Combes |
| Title: | President |

---

*[Signature Page to Assignment and Assumption Agreement]*

## Exhibit 99.1

**Exhibit 99.1**

![](ea029211101_ex99-1img1.jpg)

Defining The Quantum Reality May 2026

![](ea029211101_ex99-1img2.jpg)

2 Today's Agenda Executive Summary 3 Practical Quantum Computing: Today, Not Tomorrow 10 Pasqal's Commercial Success 16 Pasqal's Technology Advantage 22 Growth Execution & Financial Position 32

![](ea029211101_ex99-1img3.jpg)

Executive Summary 3

![](ea029211101_ex99-1img4.jpg)

Our Mission Is To Be A Global Leader In This New Era of Computing To Solve High Value Problems That Matter Optimization: Go through trillions of possibilities to find the optimal one, in real time. Simulation: Discover and design high value molecules and materials using computational methods. G L O B A L L E A D E R I N O P E R A T I O N A L H I G H C O M P L E X I T Y Q U A N T U M C O M P U T E R S Pasqal has 7 Quantum Processing Units (QPUs) in commercial use (installed) today with 3 more in production. All QPUs operate in standard data and supercomputing centers. Pasqal's commercial systems support 25+ commercial use cases for global clients. D E L I V E R I N G Q U A N T U M A D V A N T A G E T O D A Y S C A L A B L E H A R D W A R E A N D S O F T W A R E P L A T F O M R T H A T D E L I V E R S A N A L O G T O D A Y , F A U L T T O L E R A N T T O M O R R O W Pasqal is among a select group of quantum computing companies to have reached 1,000+ qubits on a single machine. Pasqal expects to deliver 10,000+ physical qubits and 200+ logical qubits with 99.9999% fidelity in 2029. Pasqal has delivered quantum advantage in materials science of existing rare earth magnetic material. F O C U S E D O N K E Y V E R T I C A L S A N D U S E C A S E S W I T H L E A D I N G G L O B A L E N T E R P R I S E S A S K E Y C U S T O M E R S Oil & Gas: Aramco Financial Services: Credit Agricole Specialty Materials: LG Electronics Logistics: CMA-CGM 4

![](ea029211101_ex99-1img5.jpg)

What Differentiates Pasqal 5 (1) Includes 3 QPUs currently in production. (2) Includes grants; as of March 2026. (3) Includes $250M Committed Convertible Financing initially announced in connection with Business Combination. COMMERCIAL QUA NTUM COMPUTING PLA TFORM A VAILABLE TODAY TO SOLVE HI GH VA LUE BUSI NESS PROBLEMS THA T M ATTER THE LEADING NEUTRAL ATOM TECHNOLOGY, PATHWAY TO HIGHEST LOGICAL QUBIT COUNT. WELL CAPITALIZED WITH $550M RAISED TO DATE (3). Commercial quantum computing platform that uniquely enables both analog and fault tolerant quantum computing at scale. 1 Full-stack offering across hardware, software and cloud, enabling low friction customer adoption. 2 Commercial traction with global blue-chip customers, industry leading 10 high qubit count systems(1), and ~€66M of booked / awarded business(2). 3 Pasqal's neutral atom technology with highest scalability, demonstrated quantum advantage and real-world applications. Operates in standard data centers without deep cryogenic cooling, uses only 4 kW of power. 4 World-class founding team led by Nobel Laureate Alain Aspect and John S. Bell Prize winner Antoine Browaeys. 5

![](ea029211101_ex99-1img6.jpg)

Delivering real-world business solutions today from cutting edge scientific breakthroughs 6 Pasqal At A Glance DEEP SCIENTIFIC HERITAGE FULLY COMMERCIAL TODAY SOVEREIGN SUPPORT WITH KEY STRATEGIC PARTNERS Quantum computing company founded by a Nobel Laureate and John S. Bell prize winner Pioneered the first trapped neutral atom demonstration Deep technical team with 70+ total PhDs across the company Robust intellectual property portfolio with 85+ patents(1) Latest-generation machine has achieved 1,024 trapped atoms Modular architecture delivering the only analog quantum computer today and an accelerated path to fault- tolerant quantum computing in 2029 10 commercial QPUs - 7 installed / 3 in production €16.5M 2025 commercial revenue €66M+(2) in booked & awarded business CURRENT CLIENTS DATA CENTERS Headquartered in France with deep support across government, academia and industry $550M+ capital raised to date(3) Backed by a high-quality investor base Supported by leading strategic partners: (4) IBM (4) (1) Includes pending patents. (2) Includes booked and awarded Business including Grants as of March 2026. (3) Includes $250M Committed Convertible Financing initially announced in connection with Business Combination. (4) Pasqal is part of the IBM Quantum Network. (5) Pasqal is part of Nvidia's NVQLink initiative.

![](ea029211101_ex99-1img7.jpg)

Our Technology And Product Roadmap Orion HARDWARE R&D COMMERCIAL HARDWARE PRODUCTS ON-PREM & CLOUD Physical qubits per QPU Logical qubits Logical fidelity 95% 98% 99,9% 99, 9999% ALGORITHM & ACCELERATED LIBRARIES Beta 100+ qubits Alpha 100+ qubits Gamma 140 – 200+ qubits Vela 200+ qubits First QA Centaurus Analog & Early FTQC Lyra Analog & Impactful FTQC Open-source libraries Quantum application 2 0 2 2 2 0 2 3 2 0 2 4 2 0 2 5 2 0 2 6 E 2 0 2 7 E 2 0 2 8 E 2 0 2 9 E Break-even MegaQuOps 2 20 200 QA on Quantum Matter QA on Materials, Optimization & ML Optimization applications Specialized libraries for Q Simulation, Optimization and Graph ML GML apps Digital FTQC SDK and applications 10+ PIC enabled parallel 1Q gates 100+ PIC enabled parallel 2Q gates Hybrid Quantum/Classical computing Slurm integration Hybrid programming model development Low-latency HW co-location 200 1,000 10,000-50,000 7 Note: Roadmap based on management's reasonable estimates with respect to product research and development.

![](ea029211101_ex99-1img8.jpg)

Pasqal's Leadership And Founding Team 8 Wasiq Bokhari Chief Executive Officer Loïc Henriet Chief Technology Officer Co-Founder • 2022 Nobel Prize in Physics Prof. Antoine Browaeys Co-Founder • 2025 John S. Bell Prize • Rydberg blockade pioneer Dr. Georges-Olivier Reymond Co-Founder • First trapped neutral atom 2001 Technical Management Team with Operational Heritage Distinguished Founding Team Prof. Alain Aspect • Entanglement experiments

![](ea029211101_ex99-1img9.jpg)

Pasqal's First Commercial Computer Deployed Our History Pioneering The Neutral Atom Technology 9 1982 2001 2010s 2019 2024 2025 Prof. Alain Aspect's Nobel- winning entanglement experiments Achieved Rydberg blockade & quantum simulation (Prof. Antoine Browaeys) Series A €25M; first Orion Alpha QPU delivered 1,024-atom register; Aramco (Saudi Arabia) & Distriq (Canada) deliveries First trapped neutral atom (Dr. Georges Olivier-Reymond) Pasqal co-founded by Aspect, Browaeys, Reymond, Jurczak & Lahaye Series B €100M; QPUs delivered and integrated into GENCI supercomputer and Jülich HPC environments $200M Series C and $250M Committed Convertible Financing: Total $450M 1982 2001 2010s 2019 2022 2024 2025 Quantum Advantage Displayed on TmMgGaO4 Commissioning & Inauguration of Aramco QPU 2026 2026

![](ea029211101_ex99-1img10.jpg)

Practical Quantum Computing: Today, Not Tomorrow 10

![](ea029211101_ex99-1img11.jpg)

11 Quantum Computing Is The Third Pillar Of The Future Of HPC: CPU+GPU+QPU Based Computation VISUALIZATION OF A HYBRID FUTURE HPC WORKFLOW CPU GPU CPU GPU QUANTUM HPC workflows combine multiple types of specialized computing resources: Quantum computing will be one of them Complex challenges will be addressed through an iterative, hybrid process that leverages quantum, AI and classical computing The Cloud provides the essential infrastructure to integrate quantum & classical workflows, current HPC systems and next-generation hybrid computing solutions QUANTUM 11 Pasqal's Software Stack Enables Seamless Integration of Our QPUs with CPU and GPU Based Compute at Scale.

![](ea029211101_ex99-1img12.jpg)

PHASE I-II (NOW–2030)\* From Utility to Advantage PHASE III (2030–2035+)\* The "Fault-Tolerant" Era Hybrid as practical path: Quantum for hard subproblems & HPC/AI for the end-to-end workflow. Verticals focus: Materials & Chemicals, Energy, Finance, Logistics, Telco. Technical ramp: Error mitigation, Higher fidelity, Early error correction, towards delivering 200+ logical qubits in 2029. Fault tolerance unlocks scale: Large-scale, error-corrected quantum computing for reliably running general quantum algorithms. Verticals focus: Deep molecular simulation (drug discovery), advanced materials & chemistry, industrial scale optimization. Technical ramp: Robust quantum error correction, large logical-qubit systems (10,000+ logical qubits), enabling long circuits and high-accuracy results. We Deliver Quantum Revolution today Our Full Stack Platform is Unique in Delivering Industry-Leading Analog Today and FTQC in 2029 12

![](ea029211101_ex99-1img13.jpg)

Pasqal Has Delivered Quantum Advantage In Materials Simulation, Pasqal Showed Results Not Achievable Through Classical Computers. 13 PERFORMANCE USEFULNESS CLASSICAL LIMIT KCuF3, 2026 TmMgGaO4, 2026 "Math for math's sake" GBS, 2020 RCS, 2023 RCS, 2019 Quantum simulation Toy model Ising, 2024 XY, 2024 QUANTUM ADVANTAGE ZONE

![](ea029211101_ex99-1img14.jpg)

High-fidelity simulation of a real material Simulation of the material with Pasqal quantum processing unit. It matches reality Quantitative match of simulations and predictions with measurements made @MagLab. Repeatable on different machines Five QPUs gave the same answer. One-to-One Quantum Simulation Of TmMgGaO4 14 TmMgGaO4 MODEL Source: [2603.20372] One-to-one quantum simulation of a frustrated magnet with 256 qubits

![](ea029211101_ex99-1img15.jpg)

A $720B Market Opportunity By 2040 Source: Global Quantum Intelligence (GQI) as of February 2026. 2040 Projected Market $720B FINANCIAL SERVICES CROSS-SECTOR APPLICATIONS LOGISTICS & TRANSPORT LIFE SCIENCES & PHARMA ADVANCED MATERIALS & ENERGY $30B $70B $190B $200B $230B Cross-Sector / Other Security & Cryptography Materials & Life Sciences Machine Learning & AI Optimization (Finance, Logistics) PASQAL ADDRESSES ALL FIVE SEGMENTS WITH ITS DUAL ANALOG-DIGITAL CAPABILITIES Materials & optimization today; machine learning and full FTQC anticipated by 2029+ 15

![](ea029211101_ex99-1img16.jpg)

Pasqal's Commercial Success 16

![](ea029211101_ex99-1img17.jpg)

Quantum Computing Deployed Commercially Today 17 Pasqal QPUs Operating Today in Standard Data Centers Integrated within HPC Data Centers and Enterprises without deep cryogenics. QPU Architecture Built To Handle Both Analog and FTQC Modular approach provides the infrastructure for analog compute today, with simple upgrades for future fault- tolerant compute. LATEST OPERATIONAL SYSTEM – 200 QUBITS CLOUD PARTNERS

![](ea029211101_ex99-1img18.jpg)

ENERGY ▪Portfolio optimization ▪Risk modeling ▪Oil & Gas: Upstream to Downstream ▪Grid Optimization FINANCIAL SERVICES € $▪Materials discovery ▪Battery modeling ▪Molecular simulation HIGH VALUE MATERIALS & CHEMICALS LOGISTICS & MOBILITY ▪Routing High Impact Use Cases Across Multiple Industries We have executed over 25 use cases in multiple industry verticals for leading global companies

![](ea029211101_ex99-1img19.jpg)

19 Pasqal's Vertically Integrated Go-To-Market Approach HOW WE SELL Direct Sales of QPUs and cloud hours to enterprise, HPC, supercomputing and research customers. Indirect sales through Microsoft Azure and Google Cloud for cloud hours to enterprise and research customers. Ecosystem partners (e.g. CapGemini, BCG, Tata) integrate/resell Pasqal's quantum capabilities as part of broader solution deployments. WHY IT WORKS Dedicated Access: enterprise customers deploy in their own data centers. Low Barrier To Entry: cloud access provides easier access and lowers capital expenditures. Business Relevance: differentiated catalog of existing use cases for various industries. Scalability And Compatibility: integration with existing workflows. WHAT WE SELL Quantum Processor Units (QPUs) on- premises deployments to HPC and supercomputing datacenters. Cloud access to QPUs (QCaaS) via Pasqal's private cloud, Google Cloud or Microsoft Azure to enterprise and R&D community. Quantum Solutions: Enterprise software solutions on real quantum hardware to accelerate business impact. Customers get quantum solutions the way they want: On-Prem or Cloud based

![](ea029211101_ex99-1img20.jpg)

20 Pasqal Is A Global Leader In High-qubit Quantum Processing Units Source: Publicly available information as of May 2026.. (1) Includes public and private fundraising. (2) Includes $250M Committed Convertible Financing initially announced in connection with Business Combination. (3) Includes U.S. Department of Commerce investment under the CHIPS act. (3 in Production) 10 7 6 3 3 3 0 0 $550M+(2) Quantum Computer Delivered Capital Raised(1) $600M+ $4B+ $500M+ $1.2B+(3) $1.5B+(3) $1.2B+(3) $350M+(3)

![](ea029211101_ex99-1img21.jpg)

Pasqal's Software Approach Can Win The Market User Applications The front-end where users design, develop, and submit quantum programs along with specifying computational resources Resource Coordination "Middleware" that coordinates the hybrid execution environment - the bridge between classical HPC (or cloud), AI and QC QPU The core quantum engine - manages quantum processing, control, and measurement SIMPLIFIED STACK Quantum Applications Quantum SDKs Neutral Atom Programming API – QPU runtime – Operating system – Electronics Integration with HPC and Cloud – hybrid runtime environment 21 • Pasqal accelerates quantum development by providing a full-stack environment – from Software Development Kits to applications • The product enables scalable experimentation with standardized APIs and QPU interfaces • Rapidly deployable with proven use cases Key Takeaways 21% 26% 42% 11% 18% 9% 45% 27% Qubit Numbers and Register- Related Technologies QPU Operations – Fidelity and Flexibility Quantum Error Correction and Next-Gen Technologies Industrialization Optimization Quantum Simulation and Materials Quantum Machine Learning Infrastructure and Quantum Software 53+ Hardware 33+ Software 85+ Total Patents (1) Includes pending patents. (2) Pasqal is part of the IBM Quantum Network. (1) (2) IBM

![](ea029211101_ex99-1img22.jpg)

Pasqal's Technology Advantage 22

![](ea029211101_ex99-1img23.jpg)

Fundamental Advantages Of Neutral Atom Technology SCALABILITY No major roadblocks anticipated in the near-term to scale the qubit count to 10,000 qubits and beyond, following our roadmap(1) DUAL DIGITAL-ANALOG MODES The dual analog-digital capability, offers the opportunity of near-term value with analog while developing FTQC LONG COHERENCE, UNIFORMITY AND QUALITY Because our qubits are atoms, they are inherently identical and free from fabrication defects, enabling long coherence times ROOM TEMPERATURE & LOW ENERGY CONSUMPTION No cryogenics required. The system operates at room temperature, significantly reducing power consumption HYBRID QUANTUM-CLASSICAL ARCHITECTURES Integration alongside classical hardware for scalable solutions 23 (1) Roadmap based on management's reasonable estimates with respect to product research and development. Please refer to Slide 7 for additional information. Lower cost and manufacturing simplicity Ready for fault-tolerant computing upgrades Greater yields and better performance Versatility and modularity Minimal upfront CAPEX and maintenance

![](ea029211101_ex99-1img24.jpg)

Estimated max number of qubits per single QPU 1995 2000 2005 2010 2015 2020 2025 0.001 0.01 0.1 Ions Superconducting Neutral atoms Neutral atoms are most promising for scale Fidelities are rapidly achieving parity with older modalities 24 Neutral Atoms Are Considered Best-Suited To Reach Broad Quantum Advantage And FTQC At Scale 2027 ~50k ~3-6k ~100-200 Neutral atoms Super conducting Trapped ions Fidelity

![](ea029211101_ex99-1img25.jpg)

25 Why Neutral Atoms Is A Winning Modality PASQAL (Neutral Atoms) Superconducting (IBM, Google) Trapped Ion (IonQ, Quantinuum) Photonic (PsiQ, Xanadu) Annealing (D-Wave) Scalability (per QPU) 10K – 50K ~3,000–6,000 ~100–200 Theoretical only n/a Qubits today 1,024 demonstrated ~133 (Heron) 36–56 Limited 5,000+ (annealer) Connectivity All-to-all (native) Nearest neighbor All-to-all (small) Linear 20:1 Operating temp. Room / 4K ~25 mK (deep cryo) Vacuum + cryo Cryogenic detectors ~15 mK Logical overhead ~100:1 ~1,000:1 ~1,000:1 ~1,000:1 n/a Dual analog-digital ✓Yes ✗No ✗No ✗No ✗Annealing only Demonstrated Quantum advantage ✓Magnetic Materials (2026) ✗ ✗ ✗ ✗

![](ea029211101_ex99-1img26.jpg)

Technological Advancements For Scaling A Neutral Atom QPU Key technology enablers: 1. LOADING 2. MOVEMENT 3. RE-ARRANGEMENT ▪Optical architecture for large arrays: high power laser and high numerical aperture optics ▪High-fidelity assembly: optimized rearrangement + two-cycle strategy ▪Cryogenic 4 Kelvin design for extreme-high vacuum + long trapping lifetimes 26

![](ea029211101_ex99-1img27.jpg)

Results: Defect-free 1024 Atom Register 1Atoms loaded. 2 Rearranged. Few defects. 3 1,024 atoms rearranged. No defect. 1,000+ qubits REACHED 27

![](ea029211101_ex99-1img28.jpg)

From A Physical To A Logical Qubit Physical vs logical qubits Building blocks for computing with logical qubits 1 Robust physical qubits 2 Reliable atomic operations 3 All-to-all connectivity 4 Fast Qubit readout 5 Error-detecting or error-correcting code 28

![](ea029211101_ex99-1img29.jpg)

Error Detection Demonstration On A Pasqal System Implementing a [[4,2,2]] code We use 4 physical qubits (+ 1 flag qubit) to encode 2 logical qubits, with checks based on the parity Target state ۧ ȁ00 𝐿= 1 2 ۧ ȁ0000 + ۧ ȁ1111 WITHOUT ERROR DETECTION Probability ~ 40% WITH ERROR DETECTION Probability ~ 90% Experimental implementation: Raw bitstrings After post-selection on parity 29 Source: [2605.21276] Benchmarking a machine-learning differential equations solver on a neutral-atom logical processor

![](ea029211101_ex99-1img30.jpg)

Solve Differential Equations With Physical And Logical Qubits ▪We solve differential equations, and compare end-to-end performance between logical and physical qubits ▪We reach a lower error with logical qubits We believe this is the first time worldwide that differential equations can be solved using a Logical Quantum Algorithm Source: [2605.21276] Benchmarking a machine-learning differential equations solver on a neutral-atom logical processor 30

![](ea029211101_ex99-1img31.jpg)

Modular Hardware & Rapid Innovation Pasqal Customers Get Future-Proof Systems To Match Their Needs Qubit number upgrade Noise reduction Digital gates Error correction Addressability QPU 31 Modular and Upgradable Systems for Future-Proofed Excellence Pasqal's modular hardware architecture enables clients to tailor qubit count, noise performance, addressability, among others to enhance and simplify the user experience

![](ea029211101_ex99-1img32.jpg)

Growth Execution & Financial Position 32

![](ea029211101_ex99-1img33.jpg)

Growth Pillars Building a Global Presence Build a broader commercial presence across Europe, U.S., GCC and Asia Pacific with new regional teams and ongoing collaborations Scaling Quantum Computing As A Service (QCaaS) Expand cloud-based quantum access and accelerate QCaaS adoption using enterprise-ready applications and QPU emulation Enterprise-Grade Ready QPU & Manufacturing Capabilities Standardize QPU deployments and scale manufacturing to support growing demand and HPC performance needs Engage with customers in specific verticals and use cases based on analog hybrid quantum compute Enable High Value Use Cases Quantum Advantage (QA) Inflection Point Build on first demonstration of quantum advantage in materials science with impactful one-to-one simulation of rare earth material TmMgGaO4 in Q1 2026 QCaaS + Quantum Data Deliver quantum-embedded data—unavailable through classical methods—to unlock new insights in catalysis, corrosion, and memory materials 33

![](ea029211101_ex99-1img34.jpg)

34 Commercial Revenue Growth Since 2024 Creates Foundation To Drive Scale And Future Growth Expected To Be Well Capitalized To Deliver Our Roadmap ($M) (1) Pasqal audited financials. (2) Current cash on hand as of 4/30/2026. Current cash balance of €124.7M converted to USD based on EUR / USD conversion rate of 1.1595 per European Central Bank as of 4/30/2026. (3) Includes $290.6M from SPAC Trust inclusive of deferred underwriting fees of up to $12.25M, $250M of convertible note financing (to purchase $312.5M aggregate principal amount of senior unsecured convertible bonds and investment warrants) initially announced in connection with Business Combination, net of $36M fees and expenses. Does not reflect potential SPAC redemptions. Revenue (€M)(1) (2) €66M+ Booked and Awarded Business including Grants as of March 2026 10 QPUs (7 Installed, 3 in Production) 25+ Quantum Solutions Contracts in Booked and Awarded Business including Grants as of March 2026 € 3.5 € 16.5 € 14.3 € 23.7 2024 2025 Commercial Grant $504.6 $144.6 $649.1 Cash on Hand Cash Post De-SPAC De-SPAC (3)

![](ea029211101_ex99-1img35.jpg)

35 Industry Leading Manufacturing Capabilities Available to Serve Customer Demand Pasqal's Investment in Infrastructure and Processes Enables Delivery of up to 13 Quantum Computers per Annum Subject To Full Staffing and Parts Availability Expected Production Capacity Based On QPU Type Total Capacity Total Capacity 13 QPU Type QPU Productions On-Premise 3 – 4 Cloud 7 – 8 R&D 2 13 13 (1) All capacity numbers represent target throughput range. (1)

![](ea029211101_ex99-1img36.jpg)

We are a Global Leader in Industrialization of Quantum Computers Industrialization is a challenge Industrialization is the only sustainable way to commercialize and support QPUs by unlocking: ▪Repeatable delivery and fast deployment ▪Low cost-to-serve ▪High reliability & customer trust Industrialization acts as an accelerator for R&D by offering: ▪Fast and reliable integration ▪Focus R&D efforts on new technological bricks ▪Reduce time from R&D to product but a strategic asset for Pasqal ▪Industrialization must be agile and adapted to the maturity of the company. ▪Industrialization has a cost and requires resources. ▪Industrialization is gradual and requires us to anticipate on future production volumes. 36

![](ea029211101_ex99-1img37.jpg)

37 Transaction Overview Estimated Uses ($M) Rollover Equity Value $2,000.0 Cash to Balance Sheet(4) 649.1 Est. Fees and Expenses 36.0 Total $2,685.1 • Pasqal to be acquired by Bleichroeder Acquisition Corp. II at Pre- Money Equity Value of ~$2.0 billion • Transaction to result in $649.1M cash to balance sheet, assuming no redemptions or repayments • $250M committed convertible financing at announcement of BCA. Estimated Sources ($M) Issuance of Shares $2,000.0 SPAC Cash in Trust(1,4) 290.6 Pasqal Existing Cash(2) 144.6 Convertible Financing(3) 250.0 Total $2,685.1 Pro Forma Valuation at Closing ($M, except per share data) Assumed Share Price $10.00 Pro Forma Shares Outstanding (M) 264.4 Pro Forma Equity Value $2,643.7 Less: Cash (649.1) Pro Forma Enterprise Value $1,994.6 Illustrative Pro Forma Ownership(4) Existing Pasqal Shareholders, 76% Bleichroeder Shareholders, 11% Convertible Investors, 10% Bleichroeder Sponsor, 3% $2.6B Equity Value (1) Inclusive of deferred underwriting fees of up to $12.25M. As of April 30, 2026. (2) Pasqal existing cash reflects current cash balance of €124.7M as of 4/30/2026. Figures are converted to USD based on EUR / USD conversion rate of 1.1595 as of 4/30/2026. (3) $250M convertible note financing (to purchase $312.5M aggregate principal amount of senior unsecured convertible bonds and investment warrants) initially announced in connection with Business Combination. (4) Assuming no redemptions.

![](ea029211101_ex99-1img38.jpg)

Expected Use Of Proceeds TECHNOLOGY DEPLOYMENT ▪Scale production ▪Address market use cases ▪HPC integration FTQC RAMP-UP Expected to deliver 200+ logical qubits by end of 2029 ACCELERATION OF QUANTUM ADVANTAGE Build on first display of quantum advantage in materials science achieved in Q1 2026. INTERNATIONAL COMMERCIAL & ORGANIZATIONAL GROWTH in key geographies including US, GCC, APAC and EU 38

![](ea029211101_ex99-1img39.jpg)

Peer Valuation Public Comparables Recent De-SPACs Valuation as of 5/22/2026 Pro-Forma Enterprise Value Based on Business Combination Agreement Price USD, Billions Based on Company filings and other publicly available information. (1) Implied pro forma valuation based on SPAC trading price as of 5/22/2026. (1) (1) Pasqal's Valuation In Line with Peers While Delivering Growing Commercial Quantum Computing Revenues $2.0 39 (Pre-Money Valuation) $24.0 $10.7 $8.9 $4.8 $3.3 $0.7 $3.3 $2.0 $3.3 $1.7

![](ea029211101_ex99-1img40.jpg)

Disclaimer 40 These materials are provided for informational purposes only and have been prepared to assist interested parties in making their own evaluation with respect to a business combination (the "Business Combination") between Pasqal Holding SAS ("Pasqal") and Bleichroeder Acquisition Corp. II ("Bleichroeder") and related transactions and for no other purpose. These materials are being furnished solely to Business Combination counterparties (collectively, the "Recipients" and each, a "Recipient") solely to facilitate their consideration and evaluation of the Business Combination. By accepting this presentation, each recipient acknowledges and agrees to use any materials and information contained herein solely in connection with evaluating Pasqal, Bleichroeder, and their respective affiliates with respect to the Business Combination and otherwise in accordance with these terms and applicable law, including federal and state securities laws. The information provided herein is not all-inclusive, nor does it contain all information that may be desirable or required in order to properly evaluate the Business Combination discussed herein. Each recipient shall rely on its own independent analysis to assess the accuracy and completeness of all materials and information contained herein, including with respect to legal, tax and accounting. The information presented in these materials has been developed internally and/or obtained from sources believed to be reliable; however, none of Pasqal, Bleichroeder or their respective subsidiaries and affiliates, directors, officers, employees, representatives, consultants, legal counsel and/or agents (as to any person or entity, its "Representatives") guarantees nor makes any representation or warranty, express or implied, as to the accuracy, adequacy, timeliness or completeness of such information or any oral information provided in connection herewith, or any data such information generates, accepts no responsibility, obligation or liability (whether direct or indirect, in contract, tort or otherwise) in relation to any of such information and assumes no responsibility for independent verification of such information. Pasqal, Bleichroeder and each of their Representatives expressly disclaim any and all liability which may be based on this document and any errors therein or omissions therefrom. Without limiting the generality of the foregoing, no audit or review has been undertaken by an independent third party of the financial assumptions, data, results, calculations and forecasts contained, presented or referred to in this document. Without limitation of the foregoing, none of Pasqal, Bleichroeder or their respective Representatives undertakes any obligation to update or provide additional information to a Recipient concerning the Business Combination or to correct or update any of the information set forth in these materials. This presentation speaks as of the date hereof and shall not be deemed to be an indication of the state of affairs of, or the absence of any change or development in, Pasqal or Bleichroeder at any other point in time. Each Recipient acknowledges that the materials may include unaudited financial information and statistical and other industry and market data obtained from industry publications and research, surveys, studies and other similar third-party sources, in each case which may include certain adjustments thereto and which may be based on various estimates and assumptions that have not been independently verified.

![](ea029211101_ex99-1img41.jpg)

Disclaimer (Continued) 41 All statements other than statements of historical facts contained in this presentation are forward-looking statements. Forward-looking statements may generally be identified by the use of words such as "believe," "may," "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "plan," "project," "forecast," "predict," "potential," "seem," "seek," "future," "outlook," "target" or other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements are based on the current expectations of Bleichroeder and/or Pasqal's management and are subject to various known and unknown risks and uncertainties that could cause actual results to differ materially and adversely from those expressed or implied by such forward-looking statements. These statements include, among other things, statements regarding future events, the Potential Transaction between Bleichroeder and Pasqal, the estimated or anticipated future results and benefits of the combined company following the Potential Transaction, including the likelihood and ability of the parties to successfully consummate the Business Combination, future opportunities for the combined company, the committed PIPE financing, Pasqal's use of proceeds from its capital raising transactions and expectations with respect to future raises; Pasqal's expectations concerning its production capacity, workforce, employees and investments; Pasqal's expectations relating to the Potential Transaction, its plan to pursue a dual listing and timing thereof; Pasqal's research and development expectations; Pasqal's expectations relating to its governance and maintenance of status as a French legal entity; Pasqal's expectations concerning relationships with strategic partners, investors, and other third parties; and other statements that are not historical facts. Nothing in these materials is, or shall be relied on as, a promise or representation as to future performance. Any projections, forecasts and other estimates contained in these materials are for illustrative purposes only, based on various assumptions that may or may not accurately reflect future developments, and involve known and unknown risks and uncertainties that may cause actual results to differ materially from those reflected in these materials. Past performance is not indicative of future results and no representation or warranty, express or implied, is made as to the accuracy of any such projections, forecasts or other estimates. Changes in assumptions may have a material impact on the information included in these materials. Any forward-looking statements speak only as of the date they are made and each of Pasqal and Bleichroeder assumes no duty to and does not undertake to update forward-looking statements. These materials do not purport to set forth all of the terms and conditions of any Business Combination or to contain all of the information that a prospective investor may desire or require in its consideration of any Business Combination. The information presented in these materials is not guaranteed as to accuracy, does not purport to be complete and should not be used to form the basis of, be relied upon for, any investment decision. These materials shall be superseded in all respects by the disclosures, terms and conditions contained in the definitive disclosure or purchase documents, as applicable, and related information and documentation, if, as and when made, which may differ materially from the information presented in these materials. None of Pasqal, Bleichroeder or any of their respective Representatives makes any representation or warranty, express or implied, regarding the legal, tax or accounting impact of any prospective investor's investment in any Business Combination or any other matter described herein. By accepting delivery of these materials, each Recipient will be deemed to acknowledge and agree to the matters described above. If you are not the intended recipient of this document, please delete and destroy all copies immediately. This presentation also contains estimates and other statistical data made by independent third parties and by Pasqal and Bleichroeder relating to market size and growth and other data about Pasqal's industry. This data involves a number of assumptions and limitations, and each recipient is cautioned not to give undue weight to such estimates and other statistical data. The information contained in the third-party citations and websites referenced in this presentation is not incorporated by reference into this presentation. In addition, projections, assumptions and estimates of Pasqal's future performance and the future performance of the markets in which Pasqal operates are necessarily subject to a high degree of uncertainty and risk. For a description of certain risks relating to Pasqal, including its business and operations, and to the Potential Transaction, please refer to "Risk Factors" at the end of this presentation and as disclosed in the Registration Statement (as defined below).

![](ea029211101_ex99-1img42.jpg)

Disclaimer (Continued) 42 Additional Information About the Business Combination and Where to Find It Additional information about the Business Combination, including a copy of the business combination agreement was filed on March 4, 2026, by Bleichroeder in a Current Report on Form 8-K with the U.S. Securities and Exchange Comission (the "SEC"). The Business Combination will be submitted to shareholders of Bleichroeder for their consideration. Bleichroeder, Bleichroeder Acquisition France Merger Sub 2, a société anonyme formed under the laws of the Republic of France and Pasqal have jointly filed a registration statement on Form F-4 (the "Registration Statement") with the SEC, includes a proxy statement/prospectus and certain other related documents, which will serve as both the proxy statement/prospectus to be distributed to Bleichroeder's shareholders in connection with Bleichroeder's solicitation of proxies for the vote by Bleichroeder's shareholders in connection with the Business Combination and other matters described in the Registration Statement, as well as the prospectus relating to the offer of the securities to be issued to Pasqal's shareholders in connection with the completion of the Business Combination. After the Registration Statement has been declared effective, a definitive proxy statement/prospectus and other relevant documents will be mailed to Pasqal shareholders and Bleichroeder shareholders as of the record date established for voting on the Business Combination. Before making any voting or investment decision, Bleichroeder and Pasqal shareholders and other interested persons are advised to read the proxy statement/prospectus and any amendments thereto and, once available, the definitive proxy statement/prospectus, as well as other documents filed with the SEC by Bleichroeder in connection with the Business Combination, as these documents will contain important information about Bleichroeder, Pasqal and the Business Combination. Shareholders may obtain a copy of the preliminary or definitive proxy statement/prospectus, once available, as well as other documents filed by Bleichroeder with the SEC, without charge, at the SEC's website located at www.sec.gov or by directing a written request to Bleichroeder, 1345 Avenue of the Americas, Fl 47, New York, NY 10105. Participants in the Solicitation Bleichroeder, Pasqal and certain of their respective directors, executive officers and other members of management and employees may, under SEC rules, be deemed to be participants in the solicitation of proxies from Bleichroeder's shareholders in connection with the Business Combination. A list of the names of Bleichroeder's directors and executive officers and a description of their interests in Bleichroeder and the business combination is contained in the sections entitled "Directors, Executive Officers and Corporate Governance," "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters," and "Certain Relationships and Related Transactions, and Director Independence" of the Annual Report filed by Bleichroeder with the SEC on March 16 2026 and the Current Report on Form 8-K filed with the SEC on May 1, 2026, each of which is available free of charge at the SEC's website at www.sec.gov. Additional information regarding the participants in the proxy solicitation and a description of their direct and indirect interests is included in the proxy statement/prospectus. Shareholders, potential investors and other interested persons should read the proxy statement/prospectus carefully before making any voting or investment decisions. You may obtain free copies of these documents from the sources described above. No Offer or Solicitation This presentation does not constitute an officer to sell or the solicitation of an offer to buy any securities, or a solicitation of any vote or approval, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration of qualification under the securities laws of any such jurisdiction. This presentation is not, and under no circumstances is to be construed as, a prospectus, an advertisement or a public offering of the securities described herein in the United States or any other jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933, as amended, or exemptions therefrom. Investment in any securities described herein has not been approved by the SEC or any other regulatory authority nor has any authority passed upon or endorsed the merits of the offering or the accuracy or adequacy of the information contained herein. Any representation to the contrary is a criminal offense.

![](ea029211101_ex99-1img43.jpg)

Disclaimer (Continued) 43 Note Regarding Trademarks Pasqal, the Pasqal logo, and other registered or common law trade names, trademarks, or service marks of Pasqal appearing in this presentation are the property of Pasqal. This presentation contains additional trade names, trademarks, and service marks of other companies that are the property of their respective owners. Solely for convenience, Pasqal's trademarks and trade names referred to in this presentation appear without the® and TM symbols, but those references are not intended to indicate, in any way, that Pasqal will not assert, to the fullest extent under applicable law, its rights, or the right of the applicable licensor, to these trademarks and trade names.

![](ea029211101_ex99-1img44.jpg)

Risk Factors 44 The below list of risk factors has been prepared solely for purposes of the proposed private placement transaction (the "Private Placement") as part of the proposed business combination of Bleichroeder Acquisition Corp. II ("Bleichroeder") and Pasqal Holding SAS (the "Business Combination"), and solely for potential investors in the Private Placement, and not for any other purpose. All references to "Pasqal," the "Company", "us" or "our" refer to the business of Pasqal Holding SAS and its consolidated subsidiaries. The risks presented below are certain of the general risks related to the business of the Company, the Private Placement and the Business Combination, and such list is not exhaustive. The list below is qualified in its entirety by disclosures contained in future documents filed or furnished by the Company and Bleichroeder, with the U.S Securities and Exchange Commission ("SEC"), including the documents filed or furnished in connection with the proposed transactions between the Company and Bleichroeder. The risks presented in such filings will be consistent with those that would be required for a public company in its SEC filings, including with respect to the business and securities of the Company and Bleichroeder and the proposed transactions between the Company and Bleichroeder, and may differ significantly from and be more extensive than those presented below. Investing in securities (the "Securities") to be issued in connection with the Business Combination involves a high degree of risk. You should carefully consider these risks and uncertainties, together with the information in the Company's consolidated financial statements and related notes, and should carry out your own due diligence and consult with your own financial and legal advisors concerning the risks and suitability of an investment in the Private Placement, before making an investment decision. There are many risks that could affect the business and results of operations of the Company, many of which are beyond its control. If any of these risks or uncertainties occurs, the Company's business, financial condition and or operating results could be materially and adversely harmed. Additional risks and uncertainties not currently known or those currently viewed to be immaterial may also materially and adversely affect the Company's business, financial condition and/or operating results. If any of these risks or uncertainties actually occurs, the value of the Company's equity securities may decline, and any investor in the Private Placement may lose all or part of its investment. Risks Related to Our Business Capital Requirements and Cost Fluctuations. Our business and our future plans for expansion are capital intensive, and the specific timing of cash inflows and outflows may fluctuate substantially from period to period. Our operating plan may change because of factors currently unknown, and we may need to seek additional funds sooner than planned, through public or private equity or debt financings or other sources, such as strategic collaborations. Such financings may result in dilution to our shareholders, issuance of securities with priority as to liquidation and dividend and other rights more favorable than ordinary shares, imposition of debt covenants and repayment obligations or other restrictions that may adversely affect our business. There can be no assurance that financing will be available to us on favorable terms, or at all. The inability to obtain financing when needed may make it more difficult for us to operate our business or implement our growth plans. Development. Our technical roadmap and plans for commercialization involve technology that is not yet available for customers and may never become available or meet desired technical specifications. Our current and planned products are inherently complex and incorporate technology and components that have not been used for other applications and that may contain defects and errors, particularly when first introduced. Building quantum computers requires advances in both science and engineering, and Pasqal may not have the ability to deliver those advances. The markets in which we operate are still rapidly evolving and highly competitive and the impact of rapidly changing science and engineering technologies could have an impact on the delivery of our technical roadmap which means that future generations of products both in quantum annealing and in gate model may be delayed or may never be delivered. If this happens, our technical roadmap may be delayed or may never be achieved, either of which would have a material impact on our business, financial condition or results of operations.

![](ea029211101_ex99-1img45.jpg)

Risk Factors (Continued) 45 Competition. The quantum computing industry is competitive on a global scale and we may not be successful in competing in this industry or establishing and maintaining confidence in its long-term business prospects among current and future partners and customers. As the marketplace continues to mature and new technologies and competitors enter, we expect competition to intensify. Such competition may negatively impact our ability to maintain and grow consumption of its platform or put downward pressure on its prices and gross margins, any of which could materially harm our reputation, business, results of operations, and financial condition. Our Industry. The quantum technology industry is in its early stages and volatile, and if it does not develop, if it develops slower than we expect, if it develops in a manner that does not require use of our quantum solutions, if it encounters negative publicity or if our solutions do not drive commercial engagement, the growth of our business will be harmed. Strategic Partners. We have entered into, and may enter into, strategic partnerships to develop and commercialize our current and future research and development programs with other companies. We may not be successful in establishing or maintaining suitable partnerships, and we may not be able to negotiate collaboration agreements having terms satisfactory to us, or at all. Failure to make or maintain these arrangements or a delay or failure in a collaborative partner's performance under any such arrangements could harm our business and financial condition. Third Parties. We depend on, and anticipate that we will continue to depend on, various third-party suppliers, contractors, and strategic partners in order to sustain and grow our business. Our ability to commercialize and scale our neutral atom quantum technology is dependent also upon components we must source from electronics, optics and other industries. Shortages or supply interruptions in any of these components will adversely impact our financial performance. French State Influence. We may be subject to restrictions or delays in changes of control or significant investments due to French State influence and foreign investment regulations. We are subject to French foreign investment regulations, which require prior authorization from the French Ministry of the Economy for the acquisition of significant interests by non-French investors in companies operating in sensitive sectors, including quantum technology and defense. The French State, through BPI, is also a shareholder and will have representation on the board of the combined company (the "Combined Company"). As a result, we may be subject to governmental oversight and intervention in our business affairs as a result of this governance structure. Licensing and Acquisition of Intellectual Property. Licensing of intellectual property is of critical importance to our business. The licensing or acquisition of third-party intellectual property rights is a competitive area, and more established companies may also pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital resources, and greater commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third- party intellectual property rights on terms that would allow us to make an appropriate return on our investment or any return on our investment at all. If we are unable to successfully obtain rights to required third-party intellectual property rights, we may have to abandon development of our products and technologies, which could have an adverse effect on our business, financial condition, results of operations, and prospects.

![](ea029211101_ex99-1img46.jpg)

Risk Factors (Continued) 46 Risks Related to the Private Placement Capital Raise. There can be no assurance that we will be able to raise the anticipated $250 million in the Private Placement, or that the amount of funds raised in the Private Placement will be sufficient to consummate the Business Combination or for use by the Combined Company. Voting Power. The issuance of shares of the Combined Company's securities in connection with the Private Placement will dilute the voting power of the Combined Company's shareholders. Risks Related to the Business Combination Transaction Costs. Both Bleichroeder and we will incur significant transaction costs in connection with the Business Combination. Contingencies of Business Combination. The consummation of the Business Combination is subject to a number of conditions and if those conditions are not satisfied or waived, the Business Combination Agreement may be terminated in accordance with its terms and the Business Combination may not be completed. Key Personnel. The ability to successfully effect the Business Combination and the Combined Company's ability to successfully operate the business thereafter will be largely dependent upon the efforts of certain of our key personnel, all of whom we expect to stay with the Combined Company following the Business Combination. The loss of such key personnel could negatively impact the operations and financial results of the combined business. Redemption. If a significant number of Bleichroeder's ordinary shares are elected to be redeemed in connection with the Business Combination, the stock ownership of the Combined Company will be highly concentrated, which will reduce the public "float' and may have a depressive effect on the market once of the ordinary shares of the combined company. Redemptions will also reduce the amount of capital available to the Combined Company following the Business Combination. Value of Securities. If the Business Combination's benefits do not meet the expectations of investors or securities analysts, the market price of Bleichroeder's securities or, following the consummation of the Business Combination, the value of the Combined Company's securities, may decline. Stock Exchange Approval. There can be no assurance that the Combined Company's securities will be approved for listing on the chosen stock exchange or that the Combined Company will be able to comply with the continued listing standards of such stock exchange Conflicts of Interest. Some of Bleichroeder's officers and directors may have conflicts of interest that may influence or have influenced them to support or approve the Business Combination without regard to your interests or in determining whether we are an appropriate target for Bleichroeder's initial business combination. Legal Proceedings. Legal proceedings or governmental investigations in connection with the Business Combination, the outcomes of which are uncertain, could delay or prevent the completion of the Business Combination.

![](ea029211101_ex99-1img47.jpg)

Risk Factors (Continued) 47 Compliance with Laws. Changes in laws or regulations, or a failure to comply with any laws and regulations, may adversely affect us and the Combined Company's business, including Bleichroeder, and our ability to consummate the Business Combination, and results of operations. Market Price. The market price of the Combined Company's or Bleichroeder's equity securities may be volatile and decline materially as a result of volatility in our industry or the market generally, or for other reasons. Additionally, market value of companies that entered into business combination agreements with special purpose acquisition vehicles have been affected by adverse economic and market forces, which may induce downward pressure on the price and trading volume of the Combined Company's or Bleichroeder's equity securities. Operating as a Public Company. Upon consummation of the Business Combination, the Combined Company will be required to comply with additional regulatory, reporting, and corporate governance requirements applicable to public companies, including the rules and regulations of the SEC and the listing standards of the stock exchange on which the Combined Company's securities are listed. These requirements will place significant demands on the Combined Company's management, administrative, operational, and accounting resources, and will result in increased legal, accounting, compliance, and other costs that Pasqal has not historically incurred as a private company. There can be no assurance the Combined Company will have the ability to maintain internal control over financial reporting and operate as a public company. In addition, as a public company, the Combined Company will be subject to heightened public scrutiny by investors, securities analysts, and the media, which could affect the market price of its securities. The need to establish the corporate infrastructure necessary for a publicly traded company may divert management's attention from implementing the Combined Company's corporate strategy, which could delay or impede the achievement of the Combined Company's business objectives.

## Exhibit 99.2

**Exhibit 99.2**

**Pasqal and Bleichroeder Acquisition Corp. II Announce Filing of Registration Statement on Form F-4 in Connection with Proposed Business Combination**

**PARIS and NEW YORK *-* May 26, 2026 *–*** Pasqal Holding SAS ("Pasqal"), a global leader in neutral-atom quantum computing, and Bleichroeder Acquisition Corp. II (NASDAQ: BBCQ), a special purpose acquisition company ("Bleichroeder"), today announced the public filing with the U.S. Securities and Exchange Commission (the "SEC") of their joint registration statement on Form F-4 (the "Registration Statement"), which includes a preliminary proxy statement/prospectus, in connection with their proposed business combination previously announced on March 4, 2026. This filing marks a pivotal milestone for Pasqal. With one of the largest installed bases of high–qubit-count quantum computers among pure-play industry peers worldwide, Pasqal is well positioned to accelerate the development of high-performance hardware and cloud-ready software solutions. These capabilities are aimed at addressing complex, real-world challenges across optimization, simulation, and artificial intelligence, reinforcing Pasqal's potential to play a leading role in the advancement of practical quantum computing applications.

The Registration Statement, including the proxy statement/prospectus, contains key information about Bleichroeder and its securities, Pasqal's financials, technology and growth strategy, as well as the terms and conditions of the proposed business combination. The Registration Statement has not been declared effective by the SEC, and the information contained therein is not complete and is subject to change. Upon closing, the combined company is expected to operate under the name "Pasqal Holding SA" and be listed on Nasdaq. The proposed transaction remains subject to customary closing conditions, including effectiveness of the Registration Statement, approval of the business combination and related transactions by Bleichroeder shareholders, receipt of certain regulatory approvals, and Nasdaq listing approval.

Pasqal has one of the largest numbers of quantum computers deployed, operational, or in active production among pure-play quantum computing companies worldwide. Seven quantum processing units ("QPUs") are already in the field with three more in production. Every QPU is manufactured at one of Pasqal's two fully operational facilities, giving the company end-to-end control over its hardware supply chain and global deployment capabilities. Pasqal offers a full stack compute solution. In addition to industry-leading neutral-atom QPUs, Pasqal has built a cloud-based offering that allows commercial customers access to its quantum hardware today. Further, Pasqal has built a software stack that makes its QPUs simple to use and integrates seamlessly with classical compute, so customers can solve real problems by combining quantum with the classical computing they already run. The platform is supported by more than 40 clients and partners and more than 25 identified industrial use cases.

Founded by 2022 Nobel Laureate Alain Aspect, and Antoine Browaeys, one of the co-inventors of neutral-atom quantum computing, Pasqal brings together world-leading scientific expertise through a global team of more than 275 employees and active participation in an ecosystem that includes IBM, NVIDIA, Google Cloud, Microsoft Azure, and other leading technology organizations. This combination is what gives Pasqal an advantage to deliver reliable, practical quantum computing on an industrial scale.

The proposed transaction values Pasqal at $2.0 billion pre-money and is expected to provide approximately $500 million of gross proceeds to Pasqal, assuming no redemptions by Bleichroeder shareholders and the closing of the previously-announced convertible financing. Proceeds from the transaction are expected to support Pasqal's continued commercialization of its QPU offering, accelerate its roadmap toward fault-tolerant quantum computing, and expand the company's global commercial and operational capabilities.

"Today's filing marks meaningful progress as Pasqal moves toward becoming a publicly listed quantum computing company," said Wasiq Bokhari, Chief Executive Officer of Pasqal. "We believe our neutral-atom quantum computing platform is uniquely positioned to deliver what the market actually needs: practical, useful quantum computing on business-relevant problems today, and a credible, engineered path to industry-leading fault-tolerant quantum computing tomorrow — on the same hardware. This transaction is intended to provide Pasqal with the public market platform and capital to accelerate our roadmap, scale our technology, and deliver real-world quantum value to customers and partners globally."

Pasqal's neutral-atom architecture is designed and engineered for scalability, standard data center deployment, and operation across both analog and fault-tolerant quantum computing modes on the same hardware platform. Pasqal has demonstrated more than 1,000 trapped atoms and is targeting in its public roadmaps to deliver 10,000+ physical qubits per QPU and 200+ logical qubits by the end of 2029. As highlighted by Nature, in an industry first, Pasqal researchers recently explained the properties of a real-life magnetic material containing rare earth elements using analog quantum simulations. They went on to make additional predictions of measurable properties that were cross-checked and verified using neutron-scattering experiments demonstrating the power and fidelity of Pasqal's material simulations. Pasqal physicist Alexandre Dauphin noted that some calculations were already in a "quantum advantage" regime. Since announcing the proposed business combination with Bleichroeder, Pasqal has delivered a series of industry firsts across commercial deployment, hybrid high-performance computing ("HPC") integration, fault-tolerant quantum computing, applications, and external recognition:

● **D eployed Saudi Arabia's first quantum computer with Aramco inside a standard data center — an industry first for the use of quantum computing on a purely commercial, main-line business.** Pasqal and Aramco inaugurated a 200-qubit neutral-atom QPU deployed inside Aramco's standard data center in Dhahran, the Kingdom of Saudi Arabia. The system is the first quantum computer deployed in a standard data center for a purely commercial, main-line business, and is also the region's first industrial Quantum Computing as a Service (QCaaS) platform. The platform gives Aramco and other enterprise, institutional, and research users secure cloud access to quantum hardware, supporting quantum-enhanced solutions across energy, materials, logistics, and optimization, including port logistics optimization, CO₂ storage optimization, well placement, rig scheduling, and workforce development. The deployment builds on the companies' partnership announced in May 2024.

● **Deepened collaboration with NVIDIA with a new CUDA-Q integration for HPC-native hybrid workflows.** Pasqal's quantum processors are already integrated with NVIDIA CUDA-Q, and Pasqal — a member of the NVIDIA Inception program — announced a new integration of CUDA-Q with its Quantum Resource Management Interface (QRMI) runtime. The new integration enables CUDA-Q workloads to be scheduled and orchestrated on Pasqal quantum systems through standard Slurm-based HPC workflows, making Pasqal's neutral-atom QPUs native accelerators in heterogeneous HPC environments alongside CPUs and GPUs. The on-premises stack will be first deployed at CINECA to integrate with Leonardo, the EuroHPC pre-exascale supercomputer. The collaboration with NVIDIA spans developer tooling, GPU-accelerated emulation, and CUDA-Q-based hybrid algorithms, and is designed to reduce adoption friction for HPC centers, research institutions, and enterprise compute teams that already run NVIDIA infrastructure.

● **Delivered the industry's first solution of differential equations using logical qubits on a neutral-atom QPU.** Pasqal announced new research solving differential equations at the logical qubit level — the first time an end-to-end real-world application has been implemented using logical qubits on a neutral-atom quantum processor. The proof-of-concept used two logical qubits running on a Pasqal QPU and demonstrated that logical qubits reduce noise impact and deliver more accurate results than the underlying physical qubits, marking the critical transition from testing individual fault-tolerant building blocks to delivering complete, real-world computational solutions. Pasqal QPUs have the capability to perform both analog and digital (gate-based, fault-tolerant) quantum computing on the same hardware platform, allowing customers to extract value from analog quantum simulation today while progressing on the same machines toward fault-tolerant quantum computing. The full scientific paper is published on arXiv.

● **Convened the global quantum community at Pasqal Thoughts 2026 as the industry shifts from research to deployment.** Pasqal hosted its annual Pasqal Thoughts event in Paris, bringing together more than 150 participants from industry, academia, finance, and government across more than 10 countries. The event focused on the transition of quantum computing from research to operational use, with discussions spanning finance, artificial intelligence, telecommunications, satellite mission planning, energy, high-performance computing, and the infrastructure needed to bring quantum systems into real-world workflows.

● **Selected as an XPRIZE Quantum Applications finalist — advancing to Phase II.** Pasqal was selected as a finalist in the XPRIZE Quantum Applications competition, a three-year, $5 million global competition supported by Google Quantum AI, Google.org, and the Geneva Science and Diplomacy Anticipator (GESDA). The competition is explicitly designed to reward teams whose quantum solutions are not speculative but already grounded in clear, real-world use cases and ready for rigorous benchmarking against the best classical methods — a bar that targets teams operating at a high level of technical maturity. Pasqal was selected from a competitive pool of 62 wildcard registration submissions and is one of just five wildcard finalists advancing alongside the Phase I cohort into Phase II, where teams will be evaluated on quantified impact, hardware feasibility, and demonstrable advantage over classical approaches.

Pasqal may raise additional financing from a private placement of securities ("PIPE"). The proposed business combination is expected to close in the second half of 2026, subject to customary closing conditions.

**Advisors** 

Lazard Frères SAS is serving as advisor to Pasqal's Board. Orrick, Herrington & Sutcliffe LLP (France and US) is serving as legal counsel to Pasqal. Cantor Fitzgerald & Co. ("Cantor") is serving as lead capital markets and financial advisor to Bleichroeder. Reed Smith LLP (France and US) is serving as legal counsel to Bleichroeder.

**About Pasqal**

Pasqal is a global leader in delivering practical quantum computing at scale utilizing neutral atom technology and dedicated software for industry, science, and governments. Since its founding in 2019, Pasqal has leveraged Nobel Prize winning research to build high-performance quantum systems and cloud-ready software designed to address complex challenges in optimization, simulation, and artificial intelligence.

Headquartered in France, Pasqal employs over 275 people and serves over 25 clients and partners, including Aramco, CMA CGM, Crédit Agricole CIB, IBM (Pasqal is part of the IBM Quantum Network), LG Electronics, NVIDIA, OVHcloud, Sumitomo, and Thales.

**About Bleichroeder** 

Bleichroeder Acquisition Corp. II is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

**Contacts**

Investors

investors@pasqal.com

Media

pr@pasqal.com

**Forward-Looking Statements**

Certain statements herein may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally are accompanied by words such as "believe," "may," "might", "will," "estimate," "continue," "anticipate," "intend," "expect," "should," "would," "could," "plan," "predict," "project", "forecast," "believe," "potential," "seem," "seek," "target," "possible," "future," "outlook" or similar terminology or expressions that predict or indicate future events or trends. These forward-looking statements include, but are not limited to, statements regarding the proposed business combination between Bleichroeder and Pasqal, the estimated or anticipated future results and benefits of the combined company following the business combination, the use of proceeds from the business combination and related private placements, the stock exchange on which the shares of the combined company are expected to trade, future opportunities for the combined company, the additional PIPE financing and other statements that are not historical facts.

These statements are based on current expectations of Bleichroeder and/or Pasqal's management and are not predictions of actual performance. They are provided for illustrative purposes only and must not be relied on as a guarantee, prediction or definitive statement of fact or probability. Actual events and circumstances are difficult or impossible to predict and are beyond the control of Bleichroeder and Pasqal. These statements are subject to known and unknown risks, uncertainties and assumptions regarding Pasqal's business and the business combination, and actual results may differ materially. These risks and uncertainties include, but are not limited to: general economic, political, social and business conditions; uncertainty or changes with respect to laws and regulations; the inability of the parties to consummate the business combination; failure to realize the anticipated benefits of the business combination; the risk that the business combination disrupts Pasqal's current plans and operations; the risk from Pasqal pursuing an emerging technology, facing significant technical challenges and the potential that it may not achieve commercialization or market acceptance; Pasqal's reliance on strategic partners and other third parties; Pasqal's ability to maintain, protect and defend its intellectual property rights; and other risks that will be detailed from time to time in filings with the U.S. Securities and Exchange Commission (the "SEC"). The foregoing list of risk factors is not exhaustive. There may be additional risks that Pasqal and Bleichroeder presently do not know or currently believe are immaterial that could also cause actual results to differ from those contained in forward-looking statements. In addition, forward-looking statements provide Pasqal's and/or Bleichroeder's expectations, plans and forecasts of future events and views as of the date of this communication. While Pasqal and/or Bleichroeder may elect to update these forward-looking statements in the future, Pasqal and Bleichroeder specifically disclaim any obligation to do so.

**Additional Information and Where to Find It**

The business combination will be submitted to shareholders of Bleichroeder for their consideration. In connection with the business combination, Bleichroeder, Bleichroeder Acquisition France Merger Sub 2, a *société anonyme* formed under the laws of the Republic of France and Pasqal have jointly filed a registration statement on Form F-4 (the "Registration Statement") with the SEC, which includes a proxy statement/prospectus and certain other related documents, which will serve as both the proxy statement/prospectus to be distributed to its shareholders in connection with its solicitation for proxies for the vote by its shareholders in connection with the business combination and other matters to be described in the Registration Statement, as well as the prospectus relating to the offer and sale of the securities to be issued to Pasqal's shareholders in connection with the completion of the business combination. This communication is not a substitute for the Registration Statement, the definitive proxy statement/prospectus or any other document that Bleichroeder will send to its shareholders in connection with the business combination.

BEFORE MAKING ANY INVESTMENT OR VOTING DECISION, INVESTORS AND SECURITY HOLDERS ARE ADVISED TO READ, WHEN AVAILABLE, THE REGISTRATION STATEMENT, PROXY STATEMENT/PROSPECTUS AND ANY OTHER RELEVANT DOCUMENTS AND, IN EACH CASE, ANY AMENDMENTS THERETO, FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY IF AND WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE BUSINESS COMBINATION, RELATED TRANSACTIONS AND THE PARTIES TO THE BUSINESS COMBINATION. Investors and security holders will be able to obtain copies of these documents (if and when available) and other documents filed with the SEC free of charge at www.sec.gov.

**Participants in the Solicitation** 

Bleichroeder, Pasqal and certain of their respective directors, executive officers, and other members of management, employees and consultants, under SEC rules, may be deemed participants in the solicitation of proxies from Bleichroeder's shareholders with respect to the business combination. A list of the names of Bleichroeder's directors and executive officers and a description of their interests in Bleichroeder and the business combination is contained in the sections entitled "Directors, Executive Officers and Corporate Governance," "Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters," and "Certain Relationships and Related Transactions, and Director Independence" of the Annual Report filed by Bleichroeder with the SEC on March 16, 2026 and the Current Report on Form 8-K filed with the SEC on May 1, 2026, each of which is available free of charge at the SEC's website at www.sec.gov. Information regarding the persons who may, under SEC rules, be deemed participants in the solicitation of proxies from Bleichroeder's shareholders with respect to the business combination, and their direct and indirect interests, will be contained in the Registration Statement and the proxy statement/prospectus when they become available.

**No Offer or Solicitation**

This communication is for informational purposes only and is not (i) an offer to purchase, nor a solicitation of an offer to sell, subscribe for or buy any securities, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in contravention of applicable law nor (ii) the solicitation of any vote in any jurisdiction pursuant to the business combination or otherwise. No offer of securities shall be made except by means of a prospectus meeting the requirements of Section 10 of the Securities Act of 1933 or exemptions therefrom. No securities commission or securities regulatory authority has in any way passed upon the merits of the business combination or the accuracy or adequacy of this communication.